Innovate UK, on behalf of the Office for Life Sciences’ (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
Amount not publishedCloses 28 October 2026UK-wide
Limited companySMEStartupAcademic+2 more